Parabolic Drugs has invested ambitiously in developing World Class manufacturing facilities with operational excellence.
Parabolic Drugs has three state of the art manufacturing facilities across different locations and a world class CRO/R&D centre at Barwala. Its manufacturing facilities are well equipped to produce quality products while adhering to safety norms and stringent GMP compliance.
PDL’s Cephalosporin facility at Derabassi is a 27 acre site accredited by German MOH for European Good Manufacturing Practices.
This site has nine manufacturing plants that enables it to produce wide range of latest generation cephalosporin APIs and intermediates. It also has a dedicated quality control and quality assurance unit, solvent recovery units, three R&D laboratories, a pilot plant for scale-up of new technologies developed by our in-house R&D, three boilers and utilities, two warehouses and in house healthcare centre
Commissioned in fiscal 2005, the Panchkula facility houses two dedicated blocks for the manufacturing of wide range of oral penicillin products including niche penicillin APIs such as Bacampicillin, Sultamycillin and Pivampicillin The plant complies with all GMP requirements and has complete utility support with ETP, an in-house liquid nitrogen tank, and a GMP compliant water systems and chillers.
Non- Antibiotic Facility
The facility has commissioned for manufacturing non-antibiotic APIs in the new therapies such as CVS, CNS, oncology, antithrombotic, anti-diabetic and pain management. It includes QA/QC block, pilot plant, manufacturing plant with five production streams, separate finished goods processing section, solvent recovery, utilities, effluent treatment plant, canteen, stores, warehouses, hazardous reaction block and engineering and project sections.